Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120741012 | 12074101 | 2 | F | 20160804 | 20160212 | 20160804 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-009817 | BRISTOL MYERS SQUIBB | MYCOBACTERIUM HAEMNOPHILUM BONE AND JOINT INFECTION IN HIV/AIDS: CASE REPORT AND LITERATURE REVIEW | 60.00 | YR | M | Y | 0.00000 | 20160804 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120741012 | 12074101 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Unknown | UNK | U | 20972 | |||||||||
| 120741012 | 12074101 | 2 | SS | EMTRIVA | EMTRICITABINE | 1 | Unknown | UNK | U | 0 | CAPSULE | ||||||||
| 120741012 | 12074101 | 3 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 120741012 | 12074101 | 4 | C | CEPHALEXIN /00145501/ | CEPHALEXIN | 1 | Unknown | U | 0 | ||||||||||
| 120741012 | 12074101 | 5 | C | CEFAZOLIN | CEFAZOLIN | 1 | Unknown | U | 0 | ||||||||||
| 120741012 | 12074101 | 6 | C | RIFAMPICIN | RIFAMPIN | 1 | Unknown | 600 MG, QD | U | 0 | 600 | MG | QD | ||||||
| 120741012 | 12074101 | 7 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | 750 MG, QD | U | 0 | 750 | MG | QD | ||||||
| 120741012 | 12074101 | 8 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | 250 MG, QD | U | 0 | 250 | MG | QD | ||||||
| 120741012 | 12074101 | 9 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120741012 | 12074101 | 1 | Antiretroviral therapy |
| 120741012 | 12074101 | 2 | Antiretroviral therapy |
| 120741012 | 12074101 | 3 | Antiretroviral therapy |
| 120741012 | 12074101 | 4 | Product used for unknown indication |
| 120741012 | 12074101 | 5 | Product used for unknown indication |
| 120741012 | 12074101 | 6 | Product used for unknown indication |
| 120741012 | 12074101 | 7 | Product used for unknown indication |
| 120741012 | 12074101 | 8 | Product used for unknown indication |
| 120741012 | 12074101 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120741012 | 12074101 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120741012 | 12074101 | Debridement | |
| 120741012 | 12074101 | Haemophilus infection | |
| 120741012 | 12074101 | Immune reconstitution inflammatory syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |